FDA NDC Directory · JSON-LD · Markdown

Ticagrelor

NDC 72516-017 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerOryza Pharmaceuticals, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA208508
Dosage form / routeTABLET · ORAL
Active ingredientsTICAGRELOR (60 mg/1)
Marketing started20251201
Package count1

External sources

Source: openFDA. Public-domain (CC0).